Diet and Risk of Prostate Cancer Recurrence

by Jacob Schor, ND, FABNO

References

1. Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J clin Nutr. 2010;92:1223-1233.

2. Richman EL, et al. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010 Mar;91(3):712-21.

3. Ma RW, Chapman K. A systematic review of the effect of diet in prostate cancer prevention and treatment. J Hum Nutr Diet. 2009 Jun;22(3):187-99; quiz 200-2.

4. Dagnelie PC, et al. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int. 2004 May;93(8):1139-50.

5. Giovannucci E, et al. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007 Oct 1;121(7):1571-8.

6. Michaud DS, et al. A prospective study on intake of animal products and risk of prostate cancer. Cancer Causes Control. 2001 Aug;12(6):557-67.

7. World Cancer Research Fund. American Institute of Cancer Research. Food, nutrtition, physical activity and the prevention of cancer: a global perspective. Washington, DC. 2007.

8. Stacewicz-Sapuntzakis M, et al. Correlations of dietary patterns with prostate health. Mol Nutr Food Res. 2008 Jan;52(1):114-30.

9. Bogen KT, Keating GA. U.S. dietary exposures to heterocyclic amines. J Expo Anal Environ Epidemiol. 2001 May-Jun;11(3):155-68.

10. Johansson M, et al. One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1538-43.

11. Glunde K, et al. Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. Mol Pharm. 2006 Sep-Oct;3(5):496-506.

12. Boukaram C, Hannoun-Levi JM. Management of prostate cancer recurrence after definitive radiation therapy. Cancer Treat Rev. 2010 Apr;36(2):91-100.

13. Richman EL, et al. Choline intake and risk of lethal prostate cancer: incidence and survival. Am J Clin Nutr. 2012 Oct;96(4):855-863.

14. Van Blarigan EL, et al. Fat intake after prostate cancer diagnosis and mortality in the Physicians’ Health Study. Cancer Causes Control. 2015 Aug;26(8):1117-26.

15. Tat D, et al. Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™). Prostate. 2018 Jan;78(1):32-39.

16. Ahn J, et al. Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2007;16: 2623–2630.

17. Chan JM, et al. Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden). Cancer Causes Control. 1998;9:559–566.

18. Chan JM, et al. Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study. Am J Clin Nutr. 2001;74:549–554.

19. Kristal AR, et al. Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:719–725.

20. Kurahashi N, et al. Japan public health center-based prospective study G. dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev. 2008;17:930–937.

21. Mitrou PN, et al. A prospective study of dietary calcium, dairy products and prostate cancer risk (Finland). Int J Cancer. 2007;120:2466–2473.

22. Park Y, et al. Calcium, dairy foods, and risk of incident and fatal prostate cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol. 2007;166:1270–1279.

23. Qin LQ, et al. Milk consumption is a risk factor for prostate cancer: meta-analysis of case-control studies. Nutr Cancer. 2004;48:22–27.

24. Qin LQ, et al. Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies. Asia Pac J Clin Nutr. 2007;16:467–476.

25. Pettersson A, et al. Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death. Cancer Epidemiol Biomarkers Prev. 2012;21:428–436.

26. Yang M, et al. Dairy intake after prostate cancer diagnosis in relation to disease-specific and total mortality. Int J Cancer. 2015;137:2462–2469.

27. Downer MK, et al. Dairy intake in relation to prostate cancer survival. Int J Cancer. 2017;140:2060–2069.

28. Giovannucci E, et al. A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:203–210.

29. Ma J, et al. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. J Natl Cancer Inst. 2001;93:1330–1336.

30. Newmark HL, Heaney RP. Dairy products and prostate cancer risk. Nutr Cancer. 2010;62:297–299.

31. Saja MF, et al. Triglyceride-rich lipoproteins modulate the distribution and extravasation of Ly6C/Gr1(low) monocytes. Cell Rep. 2015;12:1802–1815.

32. Van Blarigan EL, et al. Fat intake after prostate cancer diagnosis and mortality in the Physicians’ Health Study. Cancer Causes Control. 2015;26:1117–1126.

33. Pettersson A, et al. Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death. Cancer Epidemiol Biomarkers Prev. 2012;21:428–436.

34. Joshu CE, et al. Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells. Cancer Prev Res (Phila). 2015 Aug;8(8):737-42.

35. Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL, et al. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol. 2008; 9:1039–1047.

36. Joshu CE, et al. Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomyin the PSA era. Cancer Prev Res (Phila). 2011; 4:544–551.

37. Bonn SE, et al. Body mass index and weight change in men with prostate cancer: progression and mortality. Cancer Causes Control. 2014; 25:933–943.

38. Lebdai S, et al. Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy. Urol Oncol. 2018 Feb;36(2):80.e17-80.e24.

39. De Nunzio C, et al. Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study. BMC Cancer. 2016 Jul 7;16:407.

40. Kenfield SA, et al. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol. 2011; 29:726–732.

41. Richman EL, et al. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res. 2011; 71:3889–3895.

42. Bonn SE, et al. Physical activity andsurvival among men diagnosed with prostate cancer. Cancer Epidemiol Biomark Prev. 2015;24:57–64.

43. Van Blarigan EL, et al. Physical Activity and Prostate Tumor Vessel Morphology: Data from the Health Professionals Follow-up Study. Cancer Prev Res (Phila). 2015 Oct;8(10):962-967.

44. Kenfield SA, et al. Smoking and prostate cancer survival and recurrence. JAMA. 2011; 305:2548–2555.

45. Rieken M, et al. Association of cigarette smoking and smoking cessation with biochemical recurrence of prostate cancer in patients treated with radical prostatectomy. Eur Urol. 2015; 68:949–956.

46. Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr. 2010; 92:1223–1233.

47. Brasky TM, et al. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst. 2013; 105:1132–1141.

48. Wilson KM, et al. Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. i. 2011; 103:876–884.

49. Geybels MS, et al. Coffee and tea consumption in relation to prostate cancer prognosis. Cancer Causes Control. 2013; 24:1947–1954.

50. Kirsh VA, et al. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst. 2007 Aug 1;99(15):1200-9.

51. Richman EL, Carroll PR, Chan JM. Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Int J Cancer. 2012; 131:201–210.

52. Yan L, Spitznagel EL. Soy consumption and prostate cancer risk in men: a revisit of a metaanalysis. Am J Clin Nutr. 2009; 89:1155–1163.

53. Chan JM, et al. Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control. 2006; 17:199–208.

54. Haseen F, et al. Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review. Prostate Cancer Prostatic Dis. 2009; 12:325–332.

55. Kenfield SA, et al. Mediterranean diet and prostate cancer risk and mortality in the Health Professionals Follow-up Study. Eur Urol. 2014 May;65(5):887-94.

56. Bauer SR, et al. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2013 Dec;73(16):1786-95.

57. Van Blarigan EL, et al. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival. Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1037-46.

58. van den Brandt PA, et al. Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):866-71.

59. Hurst R, et al. Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr. 2012 Jul;96(1):111-22.

60. Lippman SM, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009 Jan 7;301(1):39-51.

61. Kenfield SA, et al. Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst. 2014 Dec 12;107(1):360.

62. Gerstenberger JP, et al. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2015 Jan;75(1):60-9.

63. Tomaszewski JJ, et al. pact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™. J Urol. 2014 Apr;191(4):971-6.

64. Gaziano JM, et al. Multivitamins in the prevention of cancer in men: the Physicians’ Health Study II randomized controlled trial. JAMA. 2012 Nov 14;308(18):1871-80.

65. Nordström T, et al. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer. Prostate. 2016 Mar;76(4):339-48.

66. Chan JM, Van Blarigan EL, Kenfield SA. What should we tell prostate cancer patients about (secondary) prevention? Curr Opin Urol. 2014 May;24(3):318-23.

67. Peisch SF, et al. Prostate cancer progression and mortality: a review of diet and lifestyle factors. World J Urol. 2017 Jun;35(6):867-874.